Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
---|---|---|---|
USD 18.94 Billion | USD 37.80 Billion | 7.98% | 2023 |
The global Glass Syringe Market size was worth around USD 18941.61 Million in 2023 and is predicted to grow to around USD 37,801.30 Million by 2032 with a compound annual growth rate (CAGR) of roughly 7.98% between 2024 and 2032.
A glass syringe is made up of cylindrical borosilicate glass that is fitted with a piston to push the liquid out through the needle attached at one end of the tube. Glass syringes are widely utilized in syringes pump applications. They are available in different sizes, including microlitre volumes, assisting experiments with extremely less injection volumes. In addition, they possess very small volume errors and hence are regarded as ideal for high precision work. The syringe is intended to deliver biologics or drugs to the people in patient care. Furthermore, they are mostly used to connect other devices like intravenous (IV) line Luer connections, transfer units, adaptors, needless locks, or other devices. However, the growing prevalence of chronic diseases that require precise drug delivery systems is vigorously accentuating the growth of the global glass syringe market. For instance, cancer patients need appropriate healthcare resources like glass syringes to deliver medications according to the requirement of the patients.
The surging demand for easy-to-use and effective drug delivery devices is vigorously driving the growth of the global glass syringe market. The growing efforts of healthcare professionals to lower human errors is another key reason inducing the adoption of glass syringes globally. Glass prevents water vapor and oxygen from reacting with the product. While polymers glass syringes are made up of heavy metals that are not regarded as ideal for oxygen-sensitive drugs. Therefore, the cheap manufacturers in the market are launching metal-free glass syringes that are much compatible with biotechnology manufactured active ingredients.
Biotechnology manufactures active ingredients are highly concentrated vicious ingredients. The manufacturers are boosting the research and development activities in the patented production technology to stand out in a competitive market landscape. Furthermore, the manufacturers are experimenting with type 1 borosilicate glass to develop prefilled syringes. Low reactivity, good visibility, and sterile nature are some of the major advantages associated with type 1 borosilicate glass, thereby it is a widely preferred material by manufacturers in the healthcare sector.
The global glass syringe market can be segmented into application, type, syringe type, material type, and region.
By application, the market can be segmented into personal use, laboratories, and hospitals.
By type, the market can be segmented into 100ml, 50ml, 10ml, and others.
By syringe type, the market can be segmented into reusable and disposable.
By material type, the market can be segmented into type 3, type 2, and type 1. The type 1 segment accounts for the largest share in the global glass syringe market. The type 1 segment includes borosilicate glass that possesses several advantages over other materials and thereby is widely used in manufacturing syringes.
North America accounts for the largest share in the global glass syringe market due to the presence of a strong consumer base in the region. Moreover, the growing prevalence of chronic diseases like cancer in the region due to the unhealthy lifestyle of people is further likely to boost the growth of the regional market in the forthcoming years.
Asia Pacific is anticipated to witness a significant growth rate in the forthcoming years due to the presence of prominent market leaders in the region.
Glass Syringe Market: Report Scope
Report Attributes | Report Details |
---|---|
Report Name | Glass Syringe Market Size Report |
Market Size in 2023 | USD 18941.61 Million |
Market Forecast in 2032 | USD 37,801.30 Million |
Growth Rate | CAGR of 7.98% |
Number of Pages | 188 |
Forecast Units | Value (USD Billion), and Volume (Units) |
Key Companies Covered | GROUPE GUILLIN, Ampulla Ltd., Glenroy, Constantia Flexibles, Klockner Pentaplast, Nipro Corporation, Stevanato Group, SGD, Schott, UDG Healthcare, Amcor, Livcer, Sacchital SpA, BISIO PROGETTI SpA, Sampling Innovations Europe, S.L., Discos srl, VALMATIC S.r.l., Pulvorex, Lameplast Group SpA, CODAN Medizinische Geräte GmbH & Co KG, SCHOTT AG, Gerresheimer AG, Hindustan Syringes & Medical Devices Limited, NIPRO Corporation, B. Braun Medical Inc., Smiths Medical, Medtronic plc, Terumo Corporation, and Becton, Dickinson, and Company. |
Segments Covered | By type, By Application, By syringe type, By material type And By region. |
Base Year | 2023 |
Historical Year | 2018 to 2022 |
Forecast Year | 2024 - 2032 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
Some of the significant players in the global glass syringe market are -
By type :
By application:
By syringe type:
By material type:
FrequentlyAsked Questions
The surging demand for easy-to-use and effective drug delivery devices is vigorously driving the growth of the global glass syringe market. The growing efforts of healthcare professionals to lower human errors is another key reason inducing the adoption of glass syringes globally. Glass prevents water vapor and oxygen from reacting with the product. While polymers glass syringes are made up of heavy metals that are not regarded as ideal for oxygen-sensitive drugs.
Some of the significant players in the global glass syringe market are GROUPE GUILLIN, Ampulla Ltd., Glenroy, Constantia Flexibles, Klockner Pentaplast, Nipro Corporation, Stevanato Group, SGD, Schott, UDG Healthcare, Amcor, Livcer, Sacchital SpA, BISIO PROGETTI SpA, Sampling Innovations Europe, S.L.
North America accounts for the largest share in the global glass syringe market due to the presence of a strong consumer base in the region. Moreover, the growing prevalence of chronic diseases like cancer in the region due to the unhealthy lifestyle of people is further likely to boost the growth of the regional market in the forthcoming years.
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed